Press Release - 2025-04-24
Press Release - 2025-03-31
Seaport Therapeutics to Participate in Upcoming Investor Conferences in April
Press Release - 2025-03-11
Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
Press Release - 2025-03-03
Seaport Therapeutics to Participate in Two Upcoming Investor Conferences
Press Release - 2025-02-21
Seaport Therapeutics Presents New Meta-Analysis Examining Correlations Between Clinical Trial Design Factors and Placebo Response in Major Depressive Disorder Studies
Press Release - 2025-02-12
Seaport Therapeutics Announces the Publication of New Research Demonstrating Increased Lymphatic Transport with up to 55 Percent Drug Absorption via Lymphatics with GlyphTM Platform
Press Release - 2025-01-06
Seaport Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Press Release - 2024-12-11
Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Press Release - 2024-11-20
Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
Press Release - 2024-11-05
